In a surprise discovery, researchers found that cells from some types of cancers escaped destruction by the immune system by hiding inside other cancer cells.
2022
First-Line Immune Checkpoint Inhibitors Underused in Metastatic Melanoma
First-line immune checkpoint inhibitors have improved survival in patients with metastatic melanoma but remain underused in this population, according to research published in JAMA Network Open.
Sentinel node biopsy: linchpin of melanoma management
FOR patients with high-risk primary cutaneous melanomas, the most important advances in their surgical management in recent decades followed the introduction of sentinel node biopsy (SNB) in the mid-1990s and its subsequent widespread use around the world.
New study with UCLA researchers finds improvements to T-cell therapy for cancer
Researchers from UCLA, Stanford University and the University of Pennsylvania have created a system that could improve upon an existing type of therapy for cancer known as T-cell therapy.